Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perineural Dexmedetomidine for Ultrasound-Guided Infraclavicular Block
NCT07249827Phase 2Completed
- Sponsor
- McGill University Health Centre
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of dexmedetomidine in acute pain (3 arms), sponsored by McGill University Health Centre. Primary endpoint: Motor block duration. Started Dec 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT07249827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07249827.